Jun 16, 2020
eTheRNA Raises EUR 34 Million in Series B Financing to Accelerate Multiple mRNA Therapeutic Development Programs Through to Clinical Proof of Concept
Jun 11, 2020
Sirnaomics Announces Decision to Spin off RNAimmune to Develop Novel mRNA Therapeutics and Vaccines
May 19, 2020
PharmaJet and Abnova partner to develop and deliver COVID-19 mRNA Vaccine using Needle-free Injection technology
May 12, 2020
GreenLight Biosciences raises $17M financing round to accelerate large-scale manufacturing of future COVID-19 vaccines
Apr 15, 2020
Ginkgo Bioworks Provides Support on Process Optimization to Moderna for COVID-19 Response
Jan 07, 2020
TriLink BioTechnologies Expands IP Portfolio with Two New Patents
Nov 12, 2019
Skyhawk Therapeutics Announces a Second Multi-Target Collaboration Agreement with Celgene to Discover and Develop Novel Small Molecules that Modulate RNA Splicing
Sep 12, 2019
Moderna Announces Positive Phase 1 Results for the First Systemic Messenger RNA Therapeutic Encoding a Secreted Protein (mRNA-1944)
Jul 10, 2019
Visiongain Report Offers Transformative Insights on the $5.5bn mRNA Vaccines and Therapeutics Market
Mar 15, 2019
VGXI Announces Continued Progress for RNA Manufacturing Partnership
Dec 17, 2018
Lexogen upgrades the TeloPrime Full-Length cDNA Amplification Kit empowering multiple downstream applications
Oct 08, 2018
eTheRNA Opens State-of-the-art Manufacturing Facility in Belgium to Support the Development of its TriMix-based mRNA Cancer Immunotherapies
Sep 17, 2018
GeneOne Announces Expansion into RNA Vaccines and Therapeutics
Aug 27, 2018
RNA-based Therapeutics and Vaccines Market is Expected to be Account US$ 632.06 Mn By 2026: Persistence Market Research
Jun 26, 2018
Skyhawk Therapeutics Announces Strategic Collaboration with Celgene to Discover and Develop Novel mRNA Splicing Modifiers using Skyhawk's STAR* Technology Platform
Jan 23, 2018
Skyhawk Therapeutics Launches With $8 Million in Seed Financing to Advance Its Novel Platform and Portfolio of Small Molecules That Correct RNA Expression
Dec 11, 2017
Caris Life Sciences Identifies New Mechanism of Action for an Aptamer with Therapeutic Potential to Treat Non-Hodgkin Lymphoma
Oct 31, 2017
PhaseRx to Present at 5th International mRNA Conference
Oct 30, 2017
CureVac Announces Groundbreaking of Industrial-Scale GMP Production Facility for RNA Therapeutics
Oct 18, 2017
Lilly and CureVac Announce Global Collaboration to Develop mRNA Cancer Vaccines